PDA Letter Article

Global Regulators Partner for Greater Patient Access

by Ursula Busse, PhD, Novartis


A Summary of the WHO Pre-ICDRA Meeting Workshop

I had the pleasure of attending the pre-ICDRA meeting last September and was grateful much of the meeting was concerned with patient access to medicines. The event included short presentations, panel discussions and a workshop covering a lifecycle approach to medical product regulation, underscoring regulators’ responsibility to maintain constant vigilance from development to end use.